1. Toni Choueiri is a medical oncologist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital (MA, USA), where he is the leader of the Kidney Cancer Center. He serves on the NCCN Kidney/Testicular Cancer Panel and on the Medical Advisory Board of the Kidney Cancer Association and has a joint appointment at Harvard Medical School as an Assistant Professor of Medicine. He is interested in developing novel therapies in kidney cancer and in the discovery of biomarkers in this disease.
2. Ali Golshayan is an Assistant Professor of Medicine in the Division of Hematology and Oncology at the Medical University of South Carolina (SC, USA). His clinical expertise is in the treatment of kidney, bladder and prostate cancers. His research interests include applying knowledge of molecular biology to predict outcomes and introduce novel therapeutics.